Ngm Biopharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 8.61, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Ngm Biopharmaceuticals Inc 's Accounts Receivable average collection period in the Dec 31 2023 quarter, has increased to 42 days, from 39 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector 158 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1651, from overall ranking in the third quarter 2023 at 1846.

What is Receivable Turnover Ratio?
What is Ngm Biopharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NGM Receivables Turnover Ratio	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Receivable Change	-99.23 %	-	-88.97 %	1120.39 %	53.29 %
Y / Y Revenue Change	-99.09 %	-92.64 %	-82.84 %	-89.27 %	-13.25 %
Receivable Turnover Ratio (TTM)	8.61	9.37	8.53	7.37	11.81
NGM's Total Ranking	# 1651	# 1846	# 611	# 2249	# 1935
Accounts Receivable average collection period days	42	39	43	50	31
Seq. Receivable Change	-	-	-41.45 %	-83.42 %	73.06 %
Seq. Revenue Change	-71.65 %	-59.1 %	-36.67 %	-87.64 %	129.82 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 67
Healthcare Sector	# 159
Overall Market	# 1651

Receivable Turnover Ratio Statistics
High	Average	Low
1049.47	138.49	7.37
(Dec 31 2020)		(Mar 31 2023)

NGM Company Profile • Back to NGM Efficiency Comparisons • Compare NGM Receivables Turnover Ratio to its Competitors

Financial Statements
Ngm Biopharmaceuticals Inc 's Accounts Receivable	$ 0 Millions	Visit NGM's Balance sheet
Ngm Biopharmaceuticals Inc 's Sales TTM	$ 4 Millions	Visit NGM's Income Statement
Sources of NGM's Revenues		Visit NGM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NGM's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NGM's Growth Rates	NGM's Roa	NGM's Inventory Turnover Ratio	NGM's Dividend Comparisons
NGM's Profitability Ratios	NGM's Roi	NGM's Asset Turnover Ratio	NGM's Dividend Growth
NGM's Valuation Ratios	NGM's Roe	NGM's Financial Strength Ratios	NGM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2023	Receivable at quarter ending Dec 31 2023
Avalo Therapeutics Inc	202.53	$ 1.924 Millions	$ 0.010 Millions
Waters Corporation	191.98	$ 2,956.416 Millions	$ 15.399 Millions
Relay Therapeutics Inc	177.71	$ 25.546 Millions	$ 0.144 Millions
Agape Atp Corporation	176.14	$ 1.431 Millions	$ 0.008 Millions
Alpine Immune Sciences Inc	176.01	$ 58.876 Millions	$ 0.335 Millions
Nurix Therapeutics Inc	153.97	$ 76.987 Millions	$ 0.500 Millions
Healthlynked Corp	152.51	$ 5.722 Millions	$ 0.038 Millions
Scisparc Ltd	130.86	$ 2.879 Millions	$ 0.022 Millions
Electromedical Technologies Inc	119.39	$ 1.349 Millions	$ 0.011 Millions
Qiagen N v	109.89	$ 1,900.688 Millions	$ 17.296 Millions
Orthofix Medical Inc	106.89	$ 746.273 Millions	$ 6.982 Millions
Fonar Corporation	106.10	$ 102.422 Millions	$ 0.965 Millions
Lifevantage Corp	104.10	$ 210.317 Millions	$ 2.020 Millions
Silence Therapeutics Plc	102.90	$ 25.057 Millions	$ 0.244 Millions
Scynexis Inc	84.30	$ 140.141 Millions	$ 1.663 Millions
Lucid Diagnostics Inc	75.88	$ 2.428 Millions	$ 0.032 Millions
Pavmed Inc	71.68	$ 2.957 Millions	$ 0.041 Millions
Aclaris Therapeutics Inc	70.98	$ 31.249 Millions	$ 0.440 Millions
Renalytix Plc	70.60	$ 5.295 Millions	$ 0.075 Millions
Brookdale Senior Living Inc	61.31	$ 3,015.829 Millions	$ 49.189 Millions
Embecta Corp	60.93	$ 1,121.100 Millions	$ 18.400 Millions
Sangamo Therapeutics Inc	59.67	$ 176.232 Millions	$ 2.953 Millions
Palvella Therapeutics Inc	56.11	$ 42.810 Millions	$ 0.763 Millions
Neuroone Medical Technologies Corp	52.64	$ 2.816 Millions	$ 0.053 Millions
Vivos Therapeutics Inc	49.24	$ 13.271 Millions	$ 0.270 Millions
Ainos Inc	48.84	$ 0.122 Millions	$ 0.003 Millions
Vbi Vaccines Inc	48.71	$ 8.682 Millions	$ 0.178 Millions
Vireo Growth Inc.	47.94	$ 88.133 Millions	$ 1.838 Millions
Nektar Therapeutics	46.58	$ 90.122 Millions	$ 1.935 Millions
Cytomx Therapeutics Inc	45.78	$ 101.214 Millions	$ 2.211 Millions

Date modified: 2026-09-18T13:11:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.